Silverarc Capital Management »

Rhythm Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.0M 261k 22.93
2023-06-30 $1.9M 116k 16.49

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
Federated Investors
Perceptive Advisors
Commodore Capital
Checkpoint Capital
Henderson Group
Opaleye Management
T. Rowe Price Associates

View all funds holding Rhythm Pharmaceuticals